3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
7
Gastrointestinal
7
Genitourinary
4
CNS
3
Breast
3
Gynecologic
2
Other
1
Head & Neck
1
Endocrine
1
Dermatologic
1
Conditions
Stomach Ulcer
1
Stomach Neoplasms
1
Overweight
1
Obesity
1
Interventions
Metformin
9
Liraglutide
3
Exercise
3
semaglutide
2
Tirzepatide
2
Nutrition Assessment
2
Lidocaine
2
Injections
2
Docosahexaenoic Acids
2
Diet
2
sibutramine
1
polyethylene glycol 3350
1
oxycodone-acetaminophen
1
naloxegol
1
naldemedine
1
methylnaltrexone
1
Ursodeoxycholic Acid
1
Tramadol
1
Topiramate
1
Solutions
1
Sennosides
1
Resistance Training
1
Quality of Life
1
Propofol
1
Progestins
1
Polyethylene Glycols
1
Phenolphthalein
1
Oxycodone
1
Orphenadrine
1
Oral Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Propofol
×
Other
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled